| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Ventyx Biosciences Inc (NASDAQ:VTYX) shares are surging Thursday after the company announced positive Phase 2 study results for...
Ventyx shares jumped 86.5% in after-hours trading after positive Phase 2 trial results.
Ventyx Biosciences, Inc. (Nasdaq: VTYX) ("Ventyx", "Company"), today announced positive results from its Phase ...